Viewing Study NCT00174395


Ignite Creation Date: 2025-12-24 @ 1:35 PM
Ignite Modification Date: 2026-01-01 @ 10:24 AM
Study NCT ID: NCT00174395
Status: COMPLETED
Last Update Posted: 2021-01-27
First Post: 2005-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module